Sirolimus-vs Paclitaxel-Coated Balloons for Coronary Artery Disease
Sirolimus-coated balloons (SCB) and paclitaxel-coated balloons (PCB) showed comparable 1-year target lesion failure (TLF: cardiac death, target vessel-related MI, or TLR) after treatment for coronary artery disease, Dr. Pier Pasquale Leone and colleagues, Humanitas University, Italy, reported in the November 15 issue of the The American Journal of Cardiology.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations